Skip to content
ClinCalc Pro
Menu
Organic nitrate

Isosorbide mononitrate

Brand names: Imdur, Monomil, Ismo, Elantan

Isosorbide mononitrate is an oral long-acting nitrate used for the prophylaxis of angina pectoris and as an adjunct in chronic heart failure.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is converted to nitric oxide, which raises smooth-muscle cyclic GMP to produce venous and arterial dilatation, reducing cardiac preload and afterload and so lowering myocardial oxygen demand.

Prescribing in practice

  • It is contraindicated with phosphodiesterase-5 inhibitors (such as sildenafil) because the combination can cause profound, potentially life-threatening hypotension.
  • A daily nitrate-free interval is essential to prevent tolerance, so dosing should be asymmetric rather than evenly spaced around the clock.
  • Headache and postural hypotension are common, especially on initiation and dose increases.

Monitoring

Monitor for symptomatic benefit and for hypotension, with blood pressure review particularly after initiation or dose change.

Counselling the patient

  • Do not use erectile-dysfunction medicines such as sildenafil while taking nitrates.
  • Headaches are common at first and usually ease with continued treatment; tell your doctor if they persist.
  • Stand up slowly, as this medicine can make you feel dizzy or faint.

Evidence & guidelines

Long-acting nitrates are an established second-line antianginal option in NICE guidance for stable angina, used where beta-blockers or calcium-channel blockers are insufficient or unsuitable.

Reference: NICE NG185; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.